Related Experiment Video
Updated: Jun 12, 2025

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
If You Build It, Will They Come? Pediatric Integrative Medicine Service Utilization in a Comprehensive Cancer Center
Holly L Spraker-Perlman1, Alanis Gomez-Martinez2, R Elyse Heidelberg3
11Divisions of Pediatric Oncology & Pediatric Palliative Care, Department of Pediatrics, University of Utah, Salt Lake City, UT.
Integrative medicine (IM) services are increasingly utilized by pediatric cancer patients for symptom management. This study shows growing referrals and repeat visits, highlighting the importance of accessible complementary therapies.
Area of Science:
- Integrative Medicine
- Pediatric Oncology
- Symptom Management
Background:
- Pediatric cancer patients face significant symptom burden.
- Families seek complementary therapies alongside conventional cancer treatment.
- Integrative Medicine (IM) offers holistic symptom management and support.
Purpose of the Study:
- To assess referral trends and utilization patterns of a new pediatric IM service.
- To evaluate the initial 18 months of IM service data at a pediatric cancer center.
- To address the knowledge gap regarding IM service use in pediatric oncology.
Main Methods:
- Retrospective review of clinical metrics for IM patients from December 2020 to June 2022.
- Analysis of referral data and patient demographics.
- Descriptive statistical analysis using R version 4.3.0.
Main Results:
- 174 patients were referred, with a 10.9% no-show rate.
- Neuro-oncology diagnoses were most common (31.6%).
- Patients frequently utilized massage (56.1%) and acupoint visits (50.3%), with an average of 9.2 encounters per patient.
Conclusions:
- The pediatric IM service experienced increasing referrals and repeated utilization in its first 18 months.
- Further research is needed to explore longitudinal trends and symptom impact.
- IM services are a valuable component of comprehensive pediatric cancer care.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Preventive Healthcare Services
Patient-centered Care